The hypointense liver lesion on T2-weighted MR images and what it means

Radiographics

Volumn 30, Issue 1, 2010, Pages 1-23

  Curvo Semedo, Luís ^a   Brito, Jorge B ^a   Seco, Miguel F ^a   Costa, João F ^a   Marques, Cristina B ^a   Caseiro Alves, Filipe ^a  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77950153636     PISSN: 02715333     EISSN: 15271323     Source Type: Journal    
DOI: 10.1148/rg301095206     Document Type: Article

References (44)

1. Hussein SM. Hemorrhage. In: Hussein SM, ed. Liver MR imaging. Berlin, Germany: Springer, 2007;28-29.
2. Grazioli L, Federle MP, Brancatelli G, Ichikawa T, Olivetti L, Blachar A. Hepatic adenomas: imaging and pathologic findings. Radiographics 2001;21(4):877-892.
3. Ferlicot S, Kobeiter H, Nhieu JTV, et al. MR imaging of atypical focal nodular hyperplasia of the liver: radiology-pathology correlation. AJR Am J. Roentgenol 2004;182:1227-1231.
4. Brancatelli G, Federle MP, Grazioli L, Golfieri R, Lencioni R. Benign regenerative nodules in Budd-Chiari syndrome and other vascular disorders of the liver: radiologic-pathologic and clinical correlation. Radiographics 2002;22(4):847-862.
5. Kim T, Baron RL, Nalesnik MA. Infarcted regenerative nodules in cirrhosis: CT and MR imaging findings with pathologic correlation. AJR Am J Roentgenol 2000;175:1121-1125.
6. Bonkovsky HL. Iron and the liver. Am J Med Sci 1991;301:32-43.
7. Saokar A, Braschi M, Harisinghani M. Lymphotrophic nanoparticle enhanced MR imaging (LNMR imaging) for lymph node imaging. Abdom Imaging 2006;31:660-667.
8. Bartolozzi C, Lencioni R, Donati F, Cioni D. Abdominal MR: liver and pancreas. Eur Radiol 1999;9(8):1496-1512.
9. Martí-Bonmatí L. MR imaging characteristics of hepatic tumors. Eur Radiol 1997;7(2):249-258.
10. Terada T, Kadoya M, Nakanuma Y, Matsui O. Iron-accumulating adenomatous hyperplastic nodule with malignant foci in the cirrhotic liver: histopathologic, quantitative iron, and magnetic resonance imaging in vitro studies. Cancer 1990;65:1994-2000.
11. Williams GM. The pathogenesis of rat liver cancer caused by chemical carcinogens. Biochem Biophys Acta (CR) 1980;605:167-189.
12. Beaumont C, Le Rumeur E, Guillouzo C, et al. Ferritin is increased in diethylnitrosamine altered rat hepatocytes. Biochem Biophys Res Commun 1981;99:879-885.
13. Lescoat G, Loreal O, Moirand R, et al. Iron induction of ferritin synthesis and secretion in human hepatoma cell (HepG2) cultures. Liver 1989;9:179-185.
14. Honda H, Kaneko K, Kanazawa Y, et al. MR imaging of hepatocellular carcinomas: effect of Cu and Fe contents on signal intensity. Abdom Imaging 1997;22(1):60-66.
15. Vogl TJ, Hammerstingl R, Schwarz W. Superparamagnetic iron oxide-enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions. Radiology 1996;198:881-887.
16. Semelka RC, Helmberger TKG. Contrast agents for MR imaging of the liver. Radiology 2001;218:27-38.
17. Kitagawa K, Matsui O, Kadoya M, et al. Hepatocellular carcinomas with excessive copper accumulation: CT and MR findings. Radiology 1991;180:623-628.
18. Nakakoshi T. Copper and hepatocellular carcinoma. Radiology 2000;214(1):304-306.
19. Bremner I. Involvement of metallothionein in the hepatic metabolism of copper. J Nutr 1987;117:19-29.
20. Akhan O, Akpinar E, Karcaaltincaba M, et al. Imaging findings of liver involvement of Wilson's disease. Eur J Radiol 2009;69:147-155.
21. Ko S, Lee T, Ng S, Lin J, Cheng Y. Unusual liver MR findings of Wilson's disease in an asymptomatic 2-year-old girl. Abdom Imaging 1998;23:6-9.
22. Ito K, Hussain SM, Mitchell DG, Semelka RC. Diffuse liver disease. In: Edelman RR, Hesselink JR, Zlatkin MB, Crues III JV, eds. Clinical magnetic resonance imaging. 3rd ed. Philadelphia, Pa: Saunders, 2006;2589-2631.
23. Haratake J, Horie A, Takeda S, et al. Tissue copper content in primary and metastatic liver cancers. Acta Pathol Jap 1987;37:231-238.
24. Ebara M, Watanabe S, Kita K, et al. MR imaging of small hepatocellular carcinoma: effect of intratumoral copper content on signal intensity. Radiology 1991;180:617-621.
25. Sternlieb I. Copper and the liver. Gastroenterology 1980;78:1615-1628.
26. Seigelman ES, Outwater EK. Tissue characterization in the female pelvis by means of MR imaging. Radiology 1999;212:5-18.
27. Misra LK, Kim EE, Hazlewood CF, Todd LE, Elizondo-Riojas G. Characterization of skeletal muscles by MR imaging and relaxation times. Physiol Chem Phys Med NMR 1990;22:219-228.
28. Polak JF, Jolesz FA, Adams DF. NMR of skeletal muscle: differences in relaxation parameters related to extracellular/intracellular fluid spaces. Invest Radiol 1988;23:107-112.
29. Bartolozzi C, Cioni D, Donati F, Lencioni R. Focal liver lesions: MR imaging-pathologic correlation. Eur Radiol 2001;11(8):1374-1388.
30. Torbenson M. Review of the clinicopathological features of fibrolamellar carcinoma. Adv Anat Pathol 2007;14(3):217-223.
31. Fullerton GD, Potter JL, Dornbluth NC. NMR relaxation of protons in tissues and other macromolecular water solutions. Magn Reson Imaging 1982;1:209-226.
32. Reimer P, Tombach B. Upper abdomen: liver, pancreas, biliary system, and spleen. In Reimer P, Parizel PM, Stichnoth F-A eds: Clinical MR imaging. Berlin, Germany: Springer, 2006;272-318.
33. Hussein SM. Melanoma liver metastases I: focal type. In: Liver MR imaging. Berlin, Germany: Springer, 2007;56-57.
34. Fujita M, Horinouchi T, Ishiguro S, et al. T2-shortening effect of fibrinogen inclusions on MR imaging of hepatocellular carcinoma: case report and experimental relaxation measurement. AJR Am J Roentgenol 2004;182:459-462.
35. Bartolozzi C, Lencioni R. Ethanol injection for the treatment of hepatic tumours. Eur Radiol 1996;6:682-696.
36. Sironi S, De Cobelli F, Livraghi T, et al. Small hepatocellular carcinoma treated with percutaneous ethanol injection: unenhanced and gadolinium-enhanced MR imaging followup. Radiology 1994;192:407-412.
37. Colagrande S, Politi LS, Messerini L, Mascalchi M, Villari N. Solitary necrotic nodule of the liver: imaging and correlation with pathologic features. Abdom Imaging 2003;28(1):41-44.
38. Stoupis C, Taylor HM, Paley MR, et al. The rocky liver: radiologic-pathologic correlation of calcified hepatic masses. Radiographics 1998;18:675-685.
39. Ichikawa T, Federle MP, Grazioli L, Madariaga J, Nalesnik M, Marsh W. Fibrolamellar hepatocellular carcinoma: imaging and pathologic findings in 31 recent cases. Radiology 1999;213:352-361.
40. Prasad SR, Wang H, Rosas H, et al. Fat-containing lesions of the liver: radiologic-pathologic correlation. Radiographics 2005;25(2):321-331.
41. Paulson EK, McClellan JS, Washington K, Spritzer CE, Meyers WC, Baker ME. Hepatic adenoma: MR characteristics and correlation with pathologic findings. AJR Am J Roentgenol 1994;163:113-116.
42. Stanley G, Jeffrey RB Jr, Feliz B. CT findings and histopathology of intratumoral steatosis in focal nodular hyperplasia: case report and review of the literature. J Comput Assist Tomogr 2002;26:815-817.
43. Eisenberg LB, Warshauer DM, Woosley JT, Cance WG, Bunzendahl H, Semelka RC. CT and MR imaging of hepatic focal nodular hyperplasia with peripheral steatosis. J Comput Assist Tomogr 1995;19:498-500.
44. Chaoui A, Mergo PJ, Lauwers GY. Unusual appearance of focal nodular hyperplasia with fatty change. AJR Am J Roentgenol 1998;171:1433-1434.